Comprehensive, Near Patient Hyperbilirubinemia Testing in Newborns Using Low Blood Volume

This poster was presented at PAS 2018 in Toronto, Canada.

Authors: R. Ng, M. Nuffer, M. Basmajian, D. Hull, J. Elderbroom, S. Carrell, B. Mertens, R. Sista, S. Norton and V. Pamula, Baebies, Inc., Durham, NC; and K. Fisher, C.M. Cotten and R. Goldberg, Division of Neonatology, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA; and V. Bhutani, Department of Pediatrics, Division of Neonatal & Developmental Medicine, Stanford University School of Medicine, Palo Alto, CA, USA

Neonatal jaundice is a common condition that can lead to severe hyperbilirubinemia and kernicterus if not treated promptly. Comprehensive determination of hyperbilirubinemia risk requires testing for multiple analytes, including total serum bilirubin (TSB), albumin and glucose-6-phosphate dehydrogenase (G6PD), which currently are performed separately. This poster describe a rapid, near patient comprehensive testing panel to determine hyperbilirubinemia risk from < 50 µL of whole blood using a benchtop digital microfluidic platform.